| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CORBUS PHARMACEUTICALS HLDGS | 81,302 | 552,000 | 0.21% | ||
| 52 | BIOCRYST PHARMACEUTICALS | 107,200 | 473,000 | 0.18% | Call | |
| 53 | RIGEL PHARMACEUTICAL INC | 100,000 | 367,000 | 0.14% | Call | |
| 54 | TROVAGENE INC | 80,000 | 359,000 | 0.13% | Put | |
| 55 | ARDELYX INC COM | 26,076 | 337,000 | 0.13% | ||
| 56 | Progenics Pharmaceuticals Inc | 40,000 | 253,000 | 0.09% | Call | |
| 57 | DEXTERA SURGICAL INC | 128,958 | 242,000 | 0.09% | ||
| 58 | BIOCRYST PHARMACEUTICALS | 50,600 | 223,000 | 0.08% | Put | |
| 59 | AKARI THERAPEUTICS PLC | 23,169 | 197,000 | 0.07% | ||
| 60 | IMMUNOMEDICS INCORPORATED | 58,600 | 190,000 | 0.07% | Call | |
| 61 | CombiMatrix Corp | 47,431 | 133,000 | 0.05% | ||
| 62 | APPLIED GENETIC TECHNOL CORP | 10,193 | 100,000 | 0.04% | ||
| 63 | ONCOBIOLOGICS INC - WARRANT B | 96,833 | 97,000 | 0.04% | ||
| 64 | MANNKIND CORP. | 90,000 | 56,000 | 0.02% | Put | |
| 65 | ONCOBIOLOGICS INC - WARRANT A | 96,833 | 47,000 | 0.02% | ||
| 66 | PERNIX THERAPEUTICS HLDGS IN | 73,500 | 46,000 | 0.02% | Put | |
| 67 | RIGEL PHARMACEUTICAL INC | 11,900 | 44,000 | 0.02% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-16-014991, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
